Chloe Loiseau
Overview
Explore the profile of Chloe Loiseau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goig G, Loiseau C, Maghradze N, Mchedlishvili K, Avaliani T, Brites D, et al.
N Engl J Med
. 2025 Jan;
392(1):97-99.
PMID: 39752306
No abstract available.
2.
Loiseau C, Windels E, Gygli S, Jugheli L, Maghradze N, Brites D, et al.
Nat Commun
. 2023 Apr;
14(1):1988.
PMID: 37031225
Multidrug-resistant tuberculosis (MDR-TB) is among the most frequent causes of death due to antimicrobial resistance. Although only 3% of global TB cases are MDR, geographical hotspots with up to 40%...
3.
Zurcher K, Reichmuth M, Ballif M, Loiseau C, Borrell S, Reinhard M, et al.
Lancet Microbe
. 2022 Mar;
2(7):e320-e330.
PMID: 35252901
Background: Drug resistance threatens global tuberculosis control. We aimed to examine mortality in patients with tuberculosis from high-burden countries, according to concordance or discordance of results from drug susceptibility testing...
4.
Gygli S, Loiseau C, Jugheli L, Adamia N, Trauner A, Reinhard M, et al.
Nat Med
. 2021 Jun;
27(7):1308.
PMID: 34075249
No abstract available.
5.
Gygli S, Loiseau C, Jugheli L, Adamia N, Trauner A, Reinhard M, et al.
Nat Med
. 2021 May;
27(7):1171-1177.
PMID: 34031604
Multidrug-resistant tuberculosis (MDR-TB) accounts for one third of the annual deaths due to antimicrobial resistance. Drug resistance-conferring mutations frequently cause fitness costs in bacteria. Experimental work indicates that these drug...
6.
Menardo F, Rutaihwa L, Zwyer M, Borrell S, Comas I, Conceicao E, et al.
F1000Res
. 2021 Apr;
10:60.
PMID: 33732436
Lineage 1 (L1) and 3 (L3) are two lineages of the complex (MTBC) causing tuberculosis (TB) in humans. L1 and L3 are prevalent around the rim of the Indian Ocean,...
7.
Asare P, Osei-Wusu S, Baddoo N, Bedeley E, Otchere I, Brites D, et al.
Int J Infect Dis
. 2021 Mar;
106:13-22.
PMID: 33667696
Objective: To retrospectively investigate the cause of recurring tuberculosis (rcTB) among participants with pulmonary TB recruited from a prospective population-based study conducted between July 2012 and December 2015. Methods: Mycobacterium...
8.
Coscolla M, Gagneux S, Menardo F, Loiseau C, Ruiz-Rodriguez P, Borrell S, et al.
Microb Genom
. 2021 Feb;
7(2).
PMID: 33555243
Human tuberculosis (TB) is caused by members of the complex (MTBC). The MTBC comprises several human-adapted lineages known as , as well as two lineages (L5 and L6) traditionally referred...
9.
Reichmuth M, Homke R, Zurcher K, Sander P, Avihingsanon A, Collantes J, et al.
Antimicrob Agents Chemother
. 2020 Sep;
64(11).
PMID: 32868333
Mutations in the genes of the F signaling pathway of complex, including , , , , , and , can lead to delamanid resistance. We searched for such mutations among...
10.
Loiseau C, Brites D, Reinhard M, Zurcher K, Borrell S, Ballif M, et al.
Antimicrob Agents Chemother
. 2020 Jul;
64(10).
PMID: 32718966
We analyzed 312 drug-resistant genomes of isolates collected from HIV-coinfected and HIV-negative TB patients from nine countries with a high tuberculosis burden. We found that rifampicin-resistant strains isolated from HIV-coinfected...